Cancel Preloader

NRCT PUBLICATIONS

Vaccine Trial Centre: NRCT

Jan-Dec

2024

NRCT 9-1

Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine.
Jan-Dec

2024

Aug

2025

NRCT 9-1

Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S).
Aug

2025

Nov

2025

NRCT 9-4

Effectiveness of the 13-valent pneumococcal conjugate vaccine against medically attended pneumococcal lower respiratory tract infection among older adults: a case-control study.
Nov

2025

Nov

2025

NRCT 9-2

Immune responses after two inactivated COVID-19 vaccine doses, a heterologous third dose and subsequent boosting with bivalent mRNA in adults.

Nov

2025

Apr

2026

NRCT 9-3

Long-term effectiveness of at least one dose of human papillomavirus vaccine in adolescents: A test-negative case-control study.
Apr

2026

Dec

2026

NRCT 9-4

Pneumococcal conjugate vaccines in older adults and immunocompromised individuals.
Dec

2026

Under review

2026

NRCT 9-5

Evaluation of subclinical tuberculosis among end-stage kidney disease patients on hemodialysis. Under review at Int J Infect Dis. 2026.

Under review

2026

Under review

2026

NRCT 9-5

Management of latent tuberculosis infection in patients with kidney disease. Clin Microbiol Rev. In press. 2026.

Under review

2026

Under review

2026

PhD publication

Coronavirus disease 2019 vaccination and reduced severity-related outcomes in high-risk groups in Thailand during the Omicron period. Under review. 2026.
Under review

2026